enVVeno Medical Corp Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- enVVeno Medical Corp shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2023-03-31 was $1.79M, a 20.11% decline year-over-year.
- enVVeno Medical Corp shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2022-09-30 was $2.21M, a 580.00% increase year-over-year.
- enVVeno Medical Corp shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2022-06-30 was $2.30M, a 1034.48% increase year-over-year.
- enVVeno Medical Corp shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2022-03-31 was $2.24M, a 1996.26% increase year-over-year.
- enVVeno Medical Corp shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2021 was $5.98M, a 762.45% increase from fiscal 2020.
- enVVeno Medical Corp shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2020 was $693.11K, a 26.42% decline from fiscal 2019.
- enVVeno Medical Corp shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2019 was $941.96K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2023-03-31 | $1.79M 10-Q · filed 2023-04-28 | |
| 2022-09-30 | $2.21M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $2.30M 10-Q · filed 2022-10-27 | |
| 2022-03-31 | $2.24M 10-Q · filed 2023-04-28 | |
| 2021-12-31 | $5.98M 10-K · filed 2022-03-28 | |
| 2021-09-30 | $325.00K 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $203.00K 10-Q · filed 2022-10-27 | |
| 2021-03-31 | $107.00K 10-Q · filed 2022-10-27 | |
| 2020-12-31 | $693.11K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $194.42K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $37.72K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $116.82K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $941.96K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |